US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist

20.400
-3.390-14.25%

Trading Dec 12 15:43 ET

518.46MMarket Cap-0.44P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cartesian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.250M	--
--	2024/Q4	-- / 114.290K	--
--	2024/Q3	387.000K / 1.833M	--
--	2024/Q2	33.445M / 5.506M	--
--	2024/Q1	5.840M / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.250M--

--2024/Q4-- / 114.290K--

--2024/Q3387.000K / 1.833M--

--2024/Q233.445M / 5.506M--

--2024/Q15.840M / 0.000--

Unlock Free Earnings Estimates

Open Account

Cartesian Therapeutics Earnings Reports

Cartesian Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 07:23 ET

Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7 07:08 ET

Cartesian Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 07:09 ET

Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 8 07:09 ET

Analyst Rating

Updated: Dec 12, 2024

Buy

Buy
71.43%
Hold
28.57%
Sell
0.00%

Price Target

No Data

Heat List

Overall